ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
21.394,93
-0,11%
S&P 500
6.101,24
-0,29%
Dow Jones
44.424,25
-0,32%
Euro vs US Dollar
1,05025
0,00%
Bitcoin
104.307,35
-0,40%
Pepperstone
Advertisement
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. Kanada
  5. TSXV

  6. Cannara Biotech Inc (LOVE) Börsenkurse

Cannara Biotech Inc

Cannara Biotech Inc (LOVE)

Cannara Biotech Inc
Lovesac Company
0,85
0,00
(0,00%)
Geschlossen 26 Januar 10:00PM
Verzögert um 15 Minuten

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Premium

Wichtige Statistiken und Details

Current Price
0,85
Gebot
0,85
Fragen
0,88
Volumen
26.075
0,85 Tagesbereich 0,88
0,52 52-Wochen-Bereich 1,04
Marktkapitalisierung
76,515M
Handelsende
0,85
Handelsbeginn
0,88
Letzte Trade
500
@
0.85
Letzter Handelszeitpunkt
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
25.041
Ausgegebene Aktien
90.018.000
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
11,89
Gewinn pro Aktie (EPS)
0,07
Erlöse
82,15M
Nettogewinn
6,44M

Über Cannara Biotech Inc

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
www.cannara.ca
Hauptsitz
Saint-laurent, Quebec, Can
Gegründet
-
Cannara Biotech Inc is listed in the Pharmaceutical Preparations sector of the TSX Venture Börse with ticker LOVE. The last closing price for Cannara Biotech was $0,85. Over the last year, Cannara Biotech shares have traded in a share price range of $ 0,52 to $ 1,04.

Cannara Biotech currently has 90.018.000 shares in issue. The market capitalisation of Cannara Biotech is $76,52 million. Cannara Biotech has a price to earnings ratio (PE ratio) of 11.89.

LOVE Neueste Nachrichten

Weitere Nachrichten

Cannara Provides Update on Its 2024 Annual General Meeting Materials amid Canada Post Strike

MONTREAL, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (“Cannara”, “the Company”, “us” or “we”) (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB0), a vertically integrated producer of...

16 Dezember 2024
GlobeNewswire Inc.

Cannara Biotech to Host Investor Webcast on Thursday December 19th, 2024

MONTREAL, Dec. 12, 2024 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (“Cannara”, “the Company”, “us” or “we”) (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB0), a vertically integrated producer of...

12 Dezember 2024
GlobeNewswire Inc.

Cannara Biotech Inc. Reports Q4 and Fiscal Year 2024 Results: Achieves Record Sales Growth and Operating Cash Flow, Solidifying Leadership in Canada's Cannabis Market

Record Q4 and year-end total revenues of $23.4 million and $82.2 million, representing a 28% and 43% increase compared to the same periods in 2023.Robust growth in Q4 over Q3 2024, with total...

25 November 2024
GlobeNewswire Inc.

Cannara Biotech Achieves its Highest National Market Share of 3.2% in July 2024 and Announces Investor Webcast Scheduled for August 20, 2024

MONTREAL, Aug. 16, 2024 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB0), a vertically integrated producer of premium-grade cannabis...

16 August 2024
GlobeNewswire Inc.

Cannara Biotech Reports Q3 2024 Financial Results

Gross cannabis revenues before excise taxes increased to $26.2 million in Q3 2024 from $20.6 million in Q3 2023, a $5.6 million or 27.6%, increase. Total revenues, net of excise taxes, increased...

23 Juli 2024
GlobeNewswire Inc.

Cannara Biotech Inc. Enters into Definitive Agreement to Acquire TGOD's State-of-the-Art Cultivation and Manufacturing Facility

Cannara Biotech Inc. Enters into Definitive Agreement to Acquire TGOD's State-of-the-Art Cultivation and Manufacturing Facility in Valleyfield, Quebec Newly built fully automated one...

10 Juni 2021
InvestorsHub NewsWire

Cannara Biotech Delivers Strong Q2 2021 Results

  Cannara Biotech Delivers Strong Q2 2021 Results Significant second quarter revenue generation of $1.2 million and gross profit increase to $2.1 million showcases Cannara's...

28 April 2021
InvestorsHub NewsWire
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.022.409638554220.830.890.82231990.84642976CS
40.1114.86486486490.740.890.69284950.81186344CS
120.1521.42857142860.70.890.58250410.75835439CS
260.2541.66666666670.60.890.54195530.72114431CS
52-0.06-6.593406593410.911.040.52221730.7720276CS
1560.72553.8461538460.131.150.085592950.25388109CS
2600.69431.250.161.150.0851239880.19257042CS

LOVE - Frequently Asked Questions (FAQ)

What is the current Cannara Biotech share price?
The current share price of Cannara Biotech is $ 0,85
How many Cannara Biotech shares are in issue?
Cannara Biotech has 90.018.000 shares in issue
What is the market cap of Cannara Biotech?
The market capitalisation of Cannara Biotech is CAD 76,52M
What is the 1 year trading range for Cannara Biotech share price?
Cannara Biotech has traded in the range of $ 0,52 to $ 1,04 during the past year
What is the PE ratio of Cannara Biotech?
The price to earnings ratio of Cannara Biotech is 11,89
What is the cash to sales ratio of Cannara Biotech?
The cash to sales ratio of Cannara Biotech is 0,93
What is the reporting currency for Cannara Biotech?
Cannara Biotech reports financial results in CAD
What is the latest annual turnover for Cannara Biotech?
The latest annual turnover of Cannara Biotech is CAD 82,15M
What is the latest annual profit for Cannara Biotech?
The latest annual profit of Cannara Biotech is CAD 6,44M
What is the registered address of Cannara Biotech?
The registered address for Cannara Biotech is 333 D��CARIE, SUITE 200, SAINT-LAURENT, QUEBEC, H4N 3M9
What is the Cannara Biotech website address?
The website address for Cannara Biotech is www.cannara.ca
Which industry sector does Cannara Biotech operate in?
Cannara Biotech operates in the PHARMACEUTICAL PREPARATIONS sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
ADEAdex Mining Inc
$ 0,01
(100,00%)
1.000
DEALPlaygon Games Inc
$ 0,02
(100,00%)
1,75M
TVC.HThree Valley Copper Corp
$ 0,01
(100,00%)
15,6k
GBUGabriel Resources Ltd
$ 0,01
(100,00%)
167k
MACThemac Resources Group Ltd
$ 0,08
(60,00%)
3k
NAVNAVCO Pharmaceuticals Inc
$ 0,005
(-50,00%)
16,63k
SMAR.PSmartset Services Inc
$ 0,015
(-50,00%)
30k
ETUE2gold Inc
$ 0,005
(-50,00%)
101,7k
DDDMetavista3D Inc
$ 2,30
(-49,45%)
701,59k
MXL.HMX Gold Corp
$ 0,04
(-46,67%)
1,5k
NDANeptune Digital Assets Corp
$ 2,20
(30,18%)
5,15M
BRCBlackrock Silver Corp
$ 0,355
(-11,25%)
3,79M
TDGTDG Gold Corp
$ 0,45
(-1,10%)
3,19M
GPUSAlset AI Ventures Inc
$ 0,14
(-12,50%)
2,79M
PNGKraken Robotics Inc
$ 2,87
(0,35%)
2,69M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

TSXV
LOVE
Cannara Biotech
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten